Therapeutics Monroe

Therapeutics Monroe is an addiction-treatment facility located in Pontiac, MI. The specific care levels offered by Therapeutics Monroe should be confirmed directly with the admissions team. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Therapeutics Monroe

The care-level question matters because what a facility offers is what it can realistically treat well. Care-level specifics for Therapeutics Monroe are not well-documented in the public SAMHSA record; a direct conversation with the admissions team is the reliable way to confirm what the facility actually provides. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Therapeutics Monroe's offerings match the clinical need.

Insurance and payment

Payment and insurance specifics for Therapeutics Monroe are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to Therapeutics Monroe, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Therapeutics Monroe offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.